Register here to join the call or to gain access to the recording.

Dr. Nastaran Hiedari, a product and strategy leader in genomics, precision medicine, and AI-driven healthcare innovation, will share about the role of AI in Drug Development.

Prior to entering industry, Dr. Hiedari was a postdoctoral scholar in genetics at Stanford, an Instructor in Radiation Oncology, and an Associate Faculty member at Stanford HAI. Dr. Hiedari has held product leadership roles at Thermo Fisher Scientific, Illumina, and Pfizer across molecular diagnostics, clinical genomics, product strategy, and digital transformation. Most recently, she led strategic enterprise data and AI initiatives supporting Pfizer Oncology Research & Development. She is currently the founder of BioArchai, an advisory board member at Tfive, and a strategic advisor to life sciences organizations through Guidepoint, AlphaSights, and Cepton Strategies.